Home NDC 44206-418-12 Carimune
Product NDC 44206-418
Requested package NDC 44206-418-12
11-digit product format 442060418
Labeler code 44206
Product ID 44206-418_6d78337d-6fba-4156-a522-1c03c9181489
Type PLASMA DERIVATIVE
Nonproprietary name HUMAN IMMUNOGLOBULIN G
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler CSL Behring AG
Application BLA102367
Marketing category BLA
Marketing start 2009-02-10
Marketing end 2021-05-31
Substance HUMAN IMMUNOGLOBULIN G
Active strength 12 g/1
Pharmacologic classes Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HUMAN IMMUNOGLOBULIN G ACTIVE INGREDIENT 66Y330CJHS CARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG] 8 HUMAN IMMUNOGLOBULIN G ACTIVE MOIETY 66Y330CJHS CARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG] 8 Sodium Chloride INACTIVE INGREDIENT 451W47IQ8X CARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG] 8 Sucrose INACTIVE INGREDIENT C151H8M554 CARIMUNE NANOFILTERED (HUMAN IMMUNOGLOBULIN G) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CSL BEHRING AG] 8
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 102367 Carimune, Carimune Nf, Panglobulin, Sandoglobulin Immune Globulin Intravenous (Human) 351(a) Disc 2026-06-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 44206-418-12 44206041812 1 VIAL, SINGLE-USE in 1 CARTON (44206-418-12) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (44206-418-92) 2009-02-10 2021-05-31 No No Current